PT  - JOURNAL ARTICLE
AU  - Sholukh, Anton M.
AU  - Fiore-Gartland, Andrew
AU  - Ford, Emily S.
AU  - Hou, Yixuan J.
AU  - Tse, Victor
AU  - Kaiser, Hannah
AU  - Park, Arnold
AU  - Lempp, Florian A.
AU  - Germain, Russell Saint
AU  - Bossard, Emily
AU  - Kee, Jia Jin
AU  - Diem, Kurt
AU  - Stuart, Andrew B.
AU  - Rupert, Peter B.
AU  - Brock, Chance
AU  - Buerger, Matthew
AU  - Doll, Margaret K.
AU  - Randhawa, April Kaur
AU  - Stamatatos, Leonidas
AU  - Strong, Roland K.
AU  - McLaughlin, Colleen
AU  - Jerome, Keith R.
AU  - Baric, Ralph S.
AU  - Montefiori, David
AU  - Corey, Lawrence
TI  - Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
AID  - 10.1101/2020.12.07.20245431
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.07.20245431
4099  - http://medrxiv.org/content/early/2020/12/08/2020.12.07.20245431.short
4100  - http://medrxiv.org/content/early/2020/12/08/2020.12.07.20245431.full
AB  - Determinants of protective immunity against SARS-CoV-2 infection require the development of well-standardized, reproducible antibody assays to be utilized in concert with clinical trials to establish correlates of risk and protection. This need has led to the appearance of a variety of neutralization assays used by different laboratories and companies. Using plasma samples from COVID-19 convalescent individuals with mild-to-moderate disease from a localized outbreak in a single region of the western US, we compared three platforms for SARS-CoV-2 neutralization: assay with live SARS-CoV-2, pseudovirus assay utilizing lentiviral (LV) and vesicular stomatitis virus (VSV) packaging, and a surrogate ELISA test. Vero, Vero E6, HEK293T cells expressing human angiotensin converting enzyme 2 (hACE2), and TZM-bl cells expressing hACE2 and transmembrane serine protease 2 (TMPRSS2) were evaluated. Live-virus and LV-pseudovirus assay with HEK293T cells showed similar geometric mean titers (GMTs) ranging 141–178, but VSV-pseudovirus assay yielded significantly higher GMT (310 95%CI 211-454; p < 0.001). Fifty percent neutralizing dilution (ND50) titers from live-virus and all pseudovirus assay readouts were highly correlated (Pearson r = 0.81–0.89). ND50 titers positively correlated with plasma concentration of IgG against SARS-CoV-2 spike and receptor binding domain (RBD) (r = 0.63–0.89), but moderately correlated with nucleoprotein IgG (r = 0.46–0.73). There was a moderate positive correlation between age and spike (Spearman’s rho=0.37, p=0.02), RBD (rho=0.39, p=0.013) and nucleoprotein IgG (rho=0.45, p=0.003). ND80 showed stronger correlation with age than ND50 (ND80 rho=0.51 (p=0.001), ND50 rho=0.28 (p=0.075)). Our data demonstrate high concordance between cell-based assays with live and pseudotyped virions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by: NIAID Service Agreement 225472-99 to RKS, R01AI134878 and UM1AI068614 to LC, Fred Hutch Evergreen grant to AMS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Fred Hutch Institutional Review Board and all study materials were provided in both English and Spanish.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A